Owlet (OWLT) Preferred Stock Liabilities (2020 - 2026)
Owlet's (OWLT) quarterly Preferred Stock Liabilities came in at $14.8 million in Q1 2026, up 240.64% year-on-year from $4.4 million in Q1 2025, and down 9.61% on a QoQ basis from $16.4 million in Q4 2025.
Owlet (OWLT) Preferred Stock Liabilities (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 6 years of Preferred Stock Liabilities data on file, last reported at $14.8 million in Q1 2026.
- On a quarterly basis, Preferred Stock Liabilities rose 240.64% year-over-year to $14.8 million in Q1 2026; TTM through Mar 2026 was $14.8 million, a 240.64% increase from a year earlier, with the FY2025 full-year figure at $16.4 million, up 26.87% from the prior year.
- Preferred Stock Liabilities for Q1 2026 stood at $14.8 million, down from $16.4 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for OWLT reached as high as $16.4 million in Q4 2025 and fell as low as $2.8 million in Q2 2024.
- Historically, Preferred Stock Liabilities has averaged $8.4 million across 4 years, with a median of $6.3 million in 2023.
- Across the five-year window, Preferred Stock Liabilities tumbled 50.72% in 2024 and jumped 240.64% in 2026, its largest moves.
- Year by year, Preferred Stock Liabilities stood at $7.9 million in 2023, then jumped by 64.7% to $12.9 million in 2024, then grew by 26.87% to $16.4 million in 2025, then declined by 9.61% to $14.8 million in 2026.
- Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $14.8 million in Q1 2026, $16.4 million in Q4 2025, and $15.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Owlet | 147.80 Mn | 106.79 Mn | 12.24 Mn | 14.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.84 Mn |
| Dec 31, 2025 | 16.41 Mn |
| Sep 30, 2025 | 15.54 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | 4.36 Mn |
| Dec 31, 2024 | 12.94 Mn |
| Sep 30, 2024 | 4.65 Mn |
| Jun 30, 2024 | 2.76 Mn |
| Dec 31, 2023 | 7.86 Mn |
| Sep 30, 2023 | 6.91 Mn |
| Jun 30, 2023 | 5.59 Mn |
| Mar 31, 2023 | 4.27 Mn |
| Jun 30, 2021 | 187.64 Mn |
| Mar 31, 2021 | 196.24 Mn |
| Dec 31, 2020 | 2.99 Mn |
| Sep 30, 2020 | 202.54 Mn |